February 2010 Archives - Silence Therapeutics

News	Events
Publications	Companies
Clinical Trials

Director’s Dealings
0 Replies

February 15, 2010

Contine Reading & Discuss→

Posted in News and Events

Jerry Randall has been appointed Senior Independent Director
0 Replies

February 12, 2010

Contine Reading & Discuss→

Posted in News and Events

Notification of Results
0 Replies

Contine Reading & Discuss→

Posted in News and Events

Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Target
0 Replies

February 08, 2010

Contine Reading & Discuss→

Posted in News and Events

Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
0 Replies

February 05, 2010

Contine Reading & Discuss→

Posted in News and Events

RXi Pharmaceuticals to Webcast Presentation at the 12th Annual BIO CEO & Investor Conference
0 Replies

February 01, 2010

WORCESTER, Mass., Feb 01, 2010 (BUSINESS WIRE) — RXi Pharmaceuticals Corporation (Nasdaq:RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that the Company’s President and Chief Executive Officer, Noah D. Beerman, will present a corporate overview at the 2010 BIO... Contine Reading & Discuss→

Posted in News